Article Per Year (5 Year)
p-Index From 2021 - 2026
3.914
P-Index
This Author published in this journals
All Journal HAYATI Journal of Biosciences Jurnal Veteriner Pharmaciana: Jurnal Kefarmasian Biota Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Indonesian Journal of Chemistry Majalah Farmasi dan Farmakologi (Trends in Pharmacy and Pharmaceutical Sciences) Jurnal Mandala Pharmacon Indonesia Dinamika Journal : Pengabdian Masyarakat Narra J INDRA: Jurnal Pengabdian kepada Masyarakat Jurnal Farmasi Indonesia
Firzan Nainu
Fakultas Farmasi, Universitas Hasanuddin
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Earth & Planetary Sciences Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Materials Science & Nanotechnology Medicine & Pharmacology Public Health Veterinary Other

Published : 36 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 36 Documents
Search

 1   2   3   4 
Optimizing Natural Deep Eutectic Solvent Citric Acid-Glucose Based Microwave-Assisted Extraction of Total Polyphenols Content from Eleutherine bulbosa (Mill.) Bulb Bohari Yusuf; Selvi Jumiatul Astati; Mirhansyah Ardana; Herman Herman; Arsyik Ibrahim; Laode Rijai; Firzan Nainu; Islamudin Ahmad
Indonesian Journal of Chemistry Vol 21, No 4 (2021)
Publisher : Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ijc.58467

Abstract

Application of natural deep eutectic solvent (NADES) citric acid-glucose-based microwave-assisted extraction (MAE) method for total polyphenol content (TPC) enriches the use of Eleutherine bulbosa (Mill.) bulb more widely and commercially. Therefore, this study aims to optimize NADES citric acid-glucose-based MAE on the TPC from E. bulbosa bulbs using response surface methodology (RSM). In the present study, the dried sample of E. bulbosa bulb was extracted using the NADES based MAE. Determination of TPC was conducted using Folin-Ciocalteau reagent and standard gallic acid, then measured using a UV-Vis spectrophotometer at 761 nm. Extraction condition optimization of the NADES based MAE method was performed using RSM with Box Behnken Design (four-factors-three-levels and 29 runs) on Design Expert v12. Based on the results study, the optimum condition extraction on the TPC enrichment was obtained at the NADES ratio (citric acid: glucose) 1:1 g/g; solid-liquid ratio 1:8 g/mL; extraction time of 15 min; and 270 Watt microwave power. The confirmation test and scale-up (50 g samples) were obtained with a 61.63 ± 2.23 mg GA/g sample.
Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis Jhonny K. Fajar; Muhammad Ilmawan; Sukamto Mamada; Endang Mutiawati; Milda Husnah; Hanifah Yusuf; Firzan Nainu; Salin Sirinam; Synat Keam; Youdiil Ophinni; Francesco Rosiello; Marhami Fahriani; Sandro GV. Rosa
Narra J Vol. 1 No. 3 (2021): December 2021
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v1i3.48

Abstract

This study was conducted to determine the prevalence of prolonged neuromuscular symptoms, including fatigue, anosmia, headache, myalgia, and joint pain in COVID-19 survivors hospitalized with mild, moderate, or severe infections worldwide. The search was conducted up to January 30th, 2021 using three databases (PubMed, Scopus, and Web of Science) to identify potentially eligible studies. Data on study characteristics, follow-up characteristics, and severity of COVID-19 during hospitalization were collected in accordance with PRISMA guidelines. The Newcastle-Ottawa scale was used to assess the quality of relevant articles. The estimated prevalence of specific prolonged neuromuscular symptoms and the association between COVID-19 severity and occurrence of prolonged neuromuscular symptoms was analyzed wherever appropriate. Database search yielded 4,050 articles and 22 articles were included for meta-analysis. The estimated prevalence of prolonged fatigue was recorded in 21.2% (95%CI: 11.9%–34.8%) of 3,730 COVID-19 survivors. Persistent anosmia was recorded in 239 of 2,600 COVID-19 survivors (9.7%, 95%CI: 6.1%–15.2%). In 84 out of 2,412 COVID-19 survivors (8.9%, 95%CI: 3.2%–22.6%), prolonged headache was observed. A total of 53 out of 1,125 COVID-19 patients (5.6%, 95%CI: 2.1%–14.2%) complained of persistent myalgia even after being discharged from the hospital. The prevalence of prolonged joint pain was in 15.4% (95%CI: 8.2%–27.2%) of subjects. Due to data scarcity on COVID-19 severity and prolonged neuromuscular symptoms, association analysis could not be conducted. Widespread concern regarding long-term impacts of COVID-19 was raised after several studies reported prolonged symptoms in COVID-19 survivors. Numerous theories have been proposed to address this concern; however, as the research on this pandemic is still ongoing, no explanation is definitive yet. Therefore, follow-up studies in COVID-19 survivors after recovery from COVID-19 are warranted to determine the pathogenesis of prolonged symptoms. PROSPERO registration: CRD42021242332.
Global acceptance and hesitancy of COVID-19 vaccination: A narrative review Wardah Hassan; Syeda K. Kazmi; Muhammad J. Tahir; Irfan Ullah; Hibban Ar Royan; Marhami Fahriani; Firzan Nainu; Sandro GV. Rosa
Narra J Vol. 1 No. 3 (2021): December 2021
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v1i3.57

Abstract

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization and has disrupted many aspects of the community around the globe. Vaccination is one of the prominent measures to control the COVID-19 pandemic. More than 120 vaccines have entered human clinical trials and at least 8 vaccines have been fully approved. However, the success of the COVID-19 vaccination programs depends on how the community accepts the vaccines. Despite COVID-19 vaccination having been initiated for a while now, more than 50% of the global population have not been vaccinated. In some low- and middle-income countries (LMICs), the vaccine coverage is less than 20%. Since the decision to accept the new vaccine is complex, understanding the factors underpinning vaccine acceptance is critical. This review aimed to summarize the COVID-19 vaccine acceptance rate around the globe as well as its associated determinants. Information from this study might be important to formulate effective strategies to increase the COVID-19 vaccine coverage, and to be able to achieve herd immunity.
Acute severe hepatitis of unknown etiology in children: A mini-review Andri Frediansyah; Malik Sallam; Amanda Yufika; Khan Sharun; Muhammad Iqhrammullah; Deepak Chandran; Sukamto S. Mamada; Dina E. Sallam; Yousef Khader; Yohannes K. Lemu; Fauzi Yusuf; James-Paul Kretchy; Ziad Abdeen; J. Smith Torres-Roman; Yogesh Acharya; Anastasia Bondarenko; Aamer Ikram; Kurnia F. Jamil; Katarzyna Kotfis; Ai Koyanagi; Lee Smith; Dewi Megawati; Marius Rademaker; Talha B. Emran; Ziad A. Memish; Sandro Vento; Firzan Nainu; Harapan Harapan
Narra J Vol. 2 No. 2 (2022): August 2022
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v2i2.83

Abstract

The emergence of acute, severe non hepA–E hepatitis of unknown etiology (ASHUE) has attracted global concern owing to the very young age of the patients and its unknown etiology. Although this condition has been linked to several possible causes, including viral infection, drugs and/or toxin exposure, the exact cause remains unknown; this makes treatment recommendation very difficult. In this review, we summarize recent updates on the clinical manifestations, complemented with laboratory results, case numbers with the global distribution and other epidemiological characteristics, and the possible etiologies. We also provide the proposed actions that could be undertaken to control and prevent further spread of this hepatitis. Since many etiological and pathological aspects of the acute non hepA–E hepatitis remain unclear, further research is needed to minimize the severe impact of this disease.
DETEKSI Salmonella enterica serovar Typhimurium DALAM PRODUK PANGAN SIAP SAJI MENGGUNAKAN METODE PCR, MELT CURVE, DAN ANALISIS HRM Sitti Nurhamidah; Muhammad Natsir Djide; Rudi Arfiansyah; Firzan Nainu
Majalah Farmasi dan Farmakologi Vol. 22 No. 1 (2018): MFF
Publisher : Faculty of Pharmacy, Hasanuddin University

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1456.388 KB) | DOI: 10.20956/mff.v22i1.5721

Abstract

Metode kultur konvensional membutuhkan waktu pengerjaan yang lama, dan sumber daya laboratorium yang besar. Olehnya itu, telah dikembangkan metode berbasis DNA dalam pengujian mikrobiologi. Tujuan penelitian ini adalah untuk menentukan metode yang tepat, dari berbagai metode berbasis DNA, dalam mendeteksi Salmonella enterica serovar Typhimurium pada produk pangan siap saji. Metode yang digunakan dalam penelitian ini adalah PCR, Melt Curve, dan Analisis HRM (High Resolution Melting). Dua gen yang digunakan sebagai target analisis molekuler dalam penelitian ini adalah invA dan fliC. Pengujian dilakukan terhadap tiga jenis sampel pangan siap saji, yaitu olahan daging, olahan unggas, dan salad buah. Hasil penelitian menunjukkan bahwa metode PCR dan Melt Curve dapat mendeteksi Salmonella enterica serovar Typhimurium menggunakan primer yang mengamplifikasi sekuens spesifik pada gen fliC. Walaupun demikian, sensitivitas yang lebih baik ditunjukkan oleh metode real-time PCR dengan nilai LOD 0,5 pg. Lebih lanjut, metode analisis HRM terbukti mampu mendeteksi Salmonella enterica serovar Typhimurium dan membedakannya dari serovar Salmonella yang lain, meskipun menggunakan primer invA yang kurang spesifik.
PENGUJIAN EKSTRAK KELUWAK TERHADAP AKTIVITAS REPRODUKSI DENGAN MODEL Drosophila melanogaster Nurul Hidayah Base; Mufidah Murdifin; Firzan Nainu
Majalah Farmasi dan Farmakologi Vol. 23 No. 1 (2019): MFF
Publisher : Faculty of Pharmacy, Hasanuddin University

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (954.154 KB) | DOI: 10.20956/mff.v23i1.6470

Abstract

Keluwak merupakan hasil fermentasi secara alami dari biji Pangi (Pangium edule Reinw) yang mengandung senyawa yang bersifat sebagai antioksidan. Senyawa antioksidan dapat mempengaruhi kondisi penuaan sel dalam tubuh dengan cara menangkal radikal bebas penyebab stress oksidatif. Penelitian bertujuan untuk mengetahui efek ekstrak keluwak terhadap aktivitas reproduksi Drosophila melanogaster. Dalam penelitian ini digunakan lalat jantan dan lalat betina yang diberi pakan normal (kontrol sehat), ekstrak keluwak 1,25% dan vitamin C selama 15 hari. Selanjutnya, jumlah total pupa dan jumlah lalat dewasa yang berhasil berkembang dari pupa dihitung setiap tiga hari. Hasil penelitian menunjukkan bahwa ekstrak keluwak 1,25 % dan vitamin C dapat meningkatkan jumlah pupa dan anak dibandingkan dengan kontrol sehat. Dengan demikian dapat disimpulkan bahwa ekstrak etanol keluwak dapat meningkatkan aktivitas reproduksi Drosophila melanogaster
Evaluasi Risiko Resistensi Insulin Akibat Simvastatin, Rosuvastatin dan Fenofibrat pada Tikus Betina (Rattus novergicus L.) Dislipidemia yang Diinduksi Kontrasepsi Oral dan Diet Tinggi Lemak Sitti Hadijah; Yulia Yusrini Djabir; Firzan Nainu
Jurnal Mandala Pharmacon Indonesia Vol. 8 No. 1 (2022): Jurnal Mandala Pharmacon Indonesia
Publisher : Program Studi Farmasi Universitas Mandala Waluya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35311/jmpi.v8i1.170

Abstract

Penelitian ini bertujuan untuk membandingkan pengaruh pemberian obat simvastatin, rosuvastatin dan fenofibrat terhadap kadar glukosa, insulin darah puasa dan nilai HOMA-IR terhadap tikus betina dislipidemia yang diinduksi kontrasepsi oral dan pakan lemak. Penelitian menggunakan 30 ekor tikus betina yang dibagi menjadi 6 kelompok perlakuan. Kelompok satu diberi pil kontrasepsi (PK) (1,5µg levonorgestrel, 0,3µg estradiol), kelompok dua diberi diet lemak (DL) (kuning telur 2ml/200gBB), kelompok tiga diberi PK+DL, kelompok empat diberi PK+DL dan terapi simvastatin (0,21 mg/kgBB), kelompok lima diberi PK+DL dan terapi rosuvastatin (0,5 mg/kgBB), serta kelompok enam diberi PK+DL dan terapi fenofibrat (8,2 mg/kgBB). Perlakuan PK dan DL berlangsung selama 60 hari, dimana terapi diberikan mulai hari ke-30 hingga ke-60. Hasil yang diperoleh menunjukkan pemberian masing-masing PK dan DL dapat meningkatkan GDP setelah 30 hari, walaupun tidak mencapai nilai signifikan. Terapi simvastatin dan rosuvastatin dan fenofibrat selama 30 hari terakhir (hari ke-30-60) dapat menurunkan kadar glukosa darah puasa (GDP) sebesar 28,17%, 45,08% dan 46,12%, namun hanya simvastatin dan rosuvastatin yang mencapai nilai signifikan. (p<0,05) Penurunan kadar insulin darah puasa paling besar pada pemberian rosuvastatin (20,64%) namun secara statistik tidak mencapai nilai signifikan. Peningkatan resistensi insulin (HOMA-IR) terlihat setelah 30 hari menggunakan pil kontrasepsi dan diet tinggi lemak. Tetapi kemudian menurun dengan pemberian simvastatin, rosuvastatin dan fenofibrat, namun hanya fenofibrat yang mencapai nilai signifikan (p<0,05). Dapat disimpulkan bahwa penggunaan simvastatin, rosuvastatin dan fenofibrat dapat menurunkan kada gula darah puasa, namun berdasarkan nilai HOMA-IR, hanya fenofibrat yang dapat menurunkan resiko resistensi insulin pada tikus betina dislipidemia yang diinduksi pil kontrasepsi dan diet tinggi lemak.
Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis - A systematic review and meta-analysis Fahriani, Marhami; Ilmawan, Muhammad; Fajar, Jonny K.; Maliga, Helnida A.; Frediansyah, Andri; Masyeni, Sri; Yusuf, Hanifah; Nainu, Firzan; Rosiello, Francesco; Sirinam, Salin; Keam, Synat; Ophinni, Youdiil
Narra J Vol. 1 No. 2 (2021): August 2021
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narraj.v1i2.36

Abstract

The study sought to determine the prevalence of persistent long COVID symptoms such as anxiety, depression, dizziness, chest pain, sleep difficulty, palpitations, weight loss, and hair loss among coronavirus disease 2019 (COVID-19) survivors worldwide and to discuss the potential pathogeneses. Potential studies were searched in three databases (PubMed, Scopus, and Web of Science) as of January 30, 2021. Data on study characteristics, patient characteristics during the follow-up, the number of patients with persistent long COVID symptoms and total COVID-19 survivors were collected according to PRISMA guidelines. To assess the quality of studies, the Newcastle-Ottawa scale was used. The estimated prevalence of each long COVID symptom and the association between COVID-19 severity and the occurrence of prolonged symptoms was assessed, if appropriate. The global prevalence of prolonged anxiety was 15.76% (95%CI: 6.36%, 25.15%). Chest pain persisted in 10.36% (239/3,224) of COVID-19 patients (95%CI: 4.92%, 15.80%). Prolonged depression was found in 24 of 548 COVID-19 survivors with an estimated prevalence of 4.32% (95%CI: 2.62%, 6.03%) and dizziness was presented in 4.83% (118/2,219, 95%CI: 1.50%, 8.16%) after recovery. Hair loss was complained by 527 of 2,251 recovered patients (cumulative prevalence of 24.76%, 95%CI: 19.60%, 29.91%), while weight loss was identified in 37 cases among 452 COVID-19 survivors (8.19%, 95%CI: 5.66%, 10.71%). Prolonged palpitation was experienced by 19.38% (211/1,926) survivors with 95%CI: 2.40%, 41.16%. Sleep difficulty was found in 541 of 2,622 COVID-19 survivors (17.87%, 95%CI: 7.55%, 28.20%). The association between COVID-19 severity and the occurrence of persistent long COVID symptoms was not analyzed due to the lack of data. In conclusion, persistent psychological symptoms are frequently reported among COVID-19 survivors. Follow-up studies with a longer duration and larger population are warranted to assess the extent of prolonged symptoms and the quality of life of COVID-19 survivors. Despite various potential pathogeneses that have been hypothesized, a definitive mechanism is yet to be addressed.
Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis Fajar, Jhonny K.; Ilmawan, Muhammad; Mamada, Sukamto; Mutiawati, Endang; Husnah, Milda; Yusuf, Hanifah; Nainu, Firzan; Sirinam, Salin; Keam, Synat; Ophinni, Youdiil; Rosiello, Francesco; Fahriani, Marhami; Rosa, Sandro GV.
Narra J Vol. 1 No. 3 (2021): December 2021
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v1i3.48

Abstract

This study was conducted to determine the prevalence of prolonged neuromuscular symptoms, including fatigue, anosmia, headache, myalgia, and joint pain in COVID-19 survivors hospitalized with mild, moderate, or severe infections worldwide. The search was conducted up to January 30th, 2021 using three databases (PubMed, Scopus, and Web of Science) to identify potentially eligible studies. Data on study characteristics, follow-up characteristics, and severity of COVID-19 during hospitalization were collected in accordance with PRISMA guidelines. The Newcastle-Ottawa scale was used to assess the quality of relevant articles. The estimated prevalence of specific prolonged neuromuscular symptoms and the association between COVID-19 severity and occurrence of prolonged neuromuscular symptoms was analyzed wherever appropriate. Database search yielded 4,050 articles and 22 articles were included for meta-analysis. The estimated prevalence of prolonged fatigue was recorded in 21.2% (95%CI: 11.9%–34.8%) of 3,730 COVID-19 survivors. Persistent anosmia was recorded in 239 of 2,600 COVID-19 survivors (9.7%, 95%CI: 6.1%–15.2%). In 84 out of 2,412 COVID-19 survivors (8.9%, 95%CI: 3.2%–22.6%), prolonged headache was observed. A total of 53 out of 1,125 COVID-19 patients (5.6%, 95%CI: 2.1%–14.2%) complained of persistent myalgia even after being discharged from the hospital. The prevalence of prolonged joint pain was in 15.4% (95%CI: 8.2%–27.2%) of subjects. Due to data scarcity on COVID-19 severity and prolonged neuromuscular symptoms, association analysis could not be conducted. Widespread concern regarding long-term impacts of COVID-19 was raised after several studies reported prolonged symptoms in COVID-19 survivors. Numerous theories have been proposed to address this concern; however, as the research on this pandemic is still ongoing, no explanation is definitive yet. Therefore, follow-up studies in COVID-19 survivors after recovery from COVID-19 are warranted to determine the pathogenesis of prolonged symptoms. PROSPERO registration: CRD42021242332.
Global acceptance and hesitancy of COVID-19 vaccination: A narrative review Hassan , Wardah; Kazmi, Syeda K.; Tahir, Muhammad J.; Ullah , Irfan; Royan, Hibban Ar; Fahriani, Marhami; Nainu, Firzan; Rosa, Sandro GV.
Narra J Vol. 1 No. 3 (2021): December 2021
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v1i3.57

Abstract

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major global health threat to human civilization and has disrupted many aspects of the community around the globe. Vaccination is one of the prominent measures to control the COVID-19 pandemic. More than 120 vaccines have entered human clinical trials and at least 8 vaccines have been fully approved. However, the success of the COVID-19 vaccination programs depends on how the community accepts the vaccines. Despite COVID-19 vaccination having been initiated for a while now, more than 50% of the global population have not been vaccinated. In some low- and middle-income countries (LMICs), the vaccine coverage is less than 20%. Since the decision to accept the new vaccine is complex, understanding the factors underpinning vaccine acceptance is critical. This review aimed to summarize the COVID-19 vaccine acceptance rate around the globe as well as its associated determinants. Information from this study might be important to formulate effective strategies to increase the COVID-19 vaccine coverage, and to be able to achieve herd immunity.
Co-Authors Aamer Ikram Abdeen, Ziad Acharya, Yogesh Ahmad Mu&#039;arif Ahmad Najib Ai Koyanagi Aksa, Rahmad Amanda Yufika Amir, Muhammad Nur Amirullah -, Amirullah Anak Agung Dewi Megawati, Anak Agung Dewi Anastasia Bondarenko Andi Maghfirah Nurul Fitri Andri Frediansyah Andri Frediansyah, Andri Arba, Muhammad Arsyik Ibrahim As'ad, Muhammad F. Asbah, Asbah Asri, Rangga M. As’ad, Muh. Fadhil Bahar, Muhammad A. Bapulo, Nurdewi N. Base, Nurul Hidayah Bob Wilffert Bohari Yusuf Bondarenko, Anastasia Chadran, Deepak Chaeratunnisa, Rizkya Chandran, Deepak Deepak Chandran Dewi Megawati Dewi Purwaningsih Dewi Yuliana Dewita Fatiah Dina E. Sallam Dini Ayu Ariastiwi B Djide, Nana Juniarti Natsir Elly Wahyudin Emil Salim Emran, Talha B. Endang Mutiawati Rahayuningsih* ENDANG MUTIAWATI, ENDANG Fahriani, Marhami Fajar, Jhonny K. Fathima, Raisha Fatmawati Fatmawati Fauzi Yusuf Fauzi Yusuf, Fauzi Filmaharani, Filmaharani Francesco Rosiello Gemini Alam Habibie Habibie HANIFAH YUSUF Hanifah Yusuf Harapan Harapan Harapan Harapan Harapan Harapan Hardiyanti, Widya Hassan , Wardah Herlina Rante Herlina Rante Herman Herman Hibban Ar Royan Husnah, Milda I Made W. Wardhana Ikram Ikram Ikram, Aamer Ilmawan, Muhammad Iqhrammullah, Muhammad Irfan Ullah Islamudin Ahmad Ismail Ismail J. Smith Torres-Roman James-Paul Kretchy Jhonny K. Fajar Jonny K. Fajar Katarzyna Kotfis Kazmi, Syeda K. Keam, Synat Khader, Yousef Khaerani, Mufliha Khairuddin - Khan Sharun Kidoura, Yuto Kotfis, Katarzyna Koyanagi, Ai Kretchy, James-Paul Kurnia F. Jamil Kurnia F. Jamil Laode Rijai Latada, Nadila P. Latada, Nadila Pratiwi Latief, Kamaluddin Latifah Rahman Lee Smith Lemu, Yohannes K. Lucia Ratna Winata Muslimin M. Natsir Djide M. Natsir Djide Maelani, Imelda Maliga, Helnida A. Malik Sallam Mamada, Sukamto Mamada, Sukamto S. Mangilep, Muhammad Agung Ady Marhami Fahriani Marianti A Manggau Marianti A.Manggau Marius Rademaker Masyeni, Sri Mellinia, Sania A. Memish, Ziad A. Milda Husnah Mirhansyah Ardana Mu'arif, Ahmad Mudatsir Mudatsir Mudjahid, Mukarram Mufidah Murdifin Muh. Akbar Bahar Muhammad Ahsan Muhammad Ilmawan Muhammad J. Tahir Muhammad Natsir Djide Mutiara, Suci Nakanishi, Yoshinobu Nalapraya, Widhy Y. Nanda, Cut M. Nirwana, Aura Nur Rahma Rumata Ophinni, Youdiil Pratama, Muhammad R. Putri, Annisa A. Putri, Tenri ZAD. Rademaker, Marius Rangga Meidianto Asri Rezky Yanuarti Risfah Yulianty Rochmat Himawan Rosa, Reski A. Rosa, Reski Amalia Rosa, Sandro GV. Rosany tayeb Rosiello, Francesco Royan, Hibban Ar Rudi Arfiansyah Rudi Arfiansyah Rudi Arfiansyah Rudi Arfiansyah sakiya syahrir sudirman Salin Sirinam Sallam, Dina E. Sallam, Malik SALSABILA, ANNISA Samsul Anwar Sandro GV. Rosa Sandro Vento Sari, Dwi K. Sarifuddin Sarifuddin Sartini Sartini Sartini Sartini Selvi Jumiatul Astati Sharun, Khan Shiratsuchi, Akiko Sirinam, Salin Sitti Hadijah Sitti Nurhamidah Smith, Lee Subehan Subehan Subehan, Subehan Suhenro, Suhenro Sukamto Mamada Sukamto S. Mamada Syahraini, Aigia Syamsu Nur, Syamsu Syeda K. Kazmi Synat Keam Tahir, Muhammad J. Takayuki Kuraishi Talha B. Emran Toriba, Akira Torres-Roman, J. Smith Tri Puspita Roska Tri Puspita Roska Ullah , Irfan Umar, Abdul H. Usmar Usmar Usmar Usmar Vento, Sandro Wardah Hassan Yesi Astri Yogesh Acharya Yohannes K. Lemu Youdiil Ophinni Yousef Khader Yufika, Amanda Yulia Yusrini Djabir Ziad A. Memish Ziad Abdeen Zubair, Muhammad S.